

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.96439954 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.96439954 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.56945170 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.56945170 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.50359347 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.11235821 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.11235821 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.11235821 |
| 9 | * cellular glucuronidation (GO:0052695) | 5.82043414 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.77694380 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.75002114 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.73525158 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.68005898 |
| 14 | omega-hydroxylase P450 pathway (GO:0097267) | 5.64990114 |
| 15 | cysteine metabolic process (GO:0006534) | 5.49875983 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.43663487 |
| 17 | * uronic acid metabolic process (GO:0006063) | 5.42239504 |
| 18 | * glucuronate metabolic process (GO:0019585) | 5.42239504 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.25088018 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.24452003 |
| 21 | urea cycle (GO:0000050) | 5.14068535 |
| 22 | urea metabolic process (GO:0019627) | 5.14068535 |
| 23 | drug metabolic process (GO:0017144) | 5.04417942 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 4.99651680 |
| 25 | response to nitrosative stress (GO:0051409) | 4.96611136 |
| 26 | bile acid metabolic process (GO:0008206) | 4.93214730 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 4.90059739 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.88776034 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88152917 |
| 30 | protein carboxylation (GO:0018214) | 4.88152917 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.82546103 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.77333684 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.74317017 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 4.70114255 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.68198105 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 4.67136568 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.66886157 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.64987379 |
| 39 | bile acid and bile salt transport (GO:0015721) | 4.62481086 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.58344351 |
| 41 | oxidative demethylation (GO:0070989) | 4.56898143 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.54381562 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.53494458 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.53494458 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.53494458 |
| 46 | regulation of complement activation (GO:0030449) | 4.48634789 |
| 47 | benzene-containing compound metabolic process (GO:0042537) | 4.46815165 |
| 48 | phenylpropanoid metabolic process (GO:0009698) | 4.45007933 |
| 49 | phospholipid efflux (GO:0033700) | 4.44785513 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 4.44515698 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.42936700 |
| 52 | intestinal absorption (GO:0050892) | 4.40491800 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.39841410 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.39841410 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 4.39170796 |
| 56 | amine catabolic process (GO:0009310) | 4.39170796 |
| 57 | negative regulation of protein activation cascade (GO:2000258) | 4.37553424 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.36611968 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.34639896 |
| 60 | drug catabolic process (GO:0042737) | 4.33497031 |
| 61 | hormone catabolic process (GO:0042447) | 4.29947066 |
| 62 | flavonoid metabolic process (GO:0009812) | 4.26571441 |
| 63 | xenobiotic catabolic process (GO:0042178) | 4.20452873 |
| 64 | lysine catabolic process (GO:0006554) | 4.17447143 |
| 65 | lysine metabolic process (GO:0006553) | 4.17447143 |
| 66 | blood coagulation, intrinsic pathway (GO:0007597) | 4.15804992 |
| 67 | negative regulation of blood coagulation (GO:0030195) | 4.13782188 |
| 68 | negative regulation of hemostasis (GO:1900047) | 4.13782188 |
| 69 | negative regulation of sterol transport (GO:0032372) | 4.11191706 |
| 70 | negative regulation of cholesterol transport (GO:0032375) | 4.11191706 |
| 71 | low-density lipoprotein particle remodeling (GO:0034374) | 4.10564250 |
| 72 | coenzyme catabolic process (GO:0009109) | 4.07862948 |
| 73 | imidazole-containing compound metabolic process (GO:0052803) | 4.07417279 |
| 74 | glutamate metabolic process (GO:0006536) | 4.06176869 |
| 75 | regulation of plasminogen activation (GO:0010755) | 4.04545811 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 4.02458119 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.99533901 |
| 78 | cholesterol efflux (GO:0033344) | 3.99299951 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 3.98343980 |
| 80 | aldehyde catabolic process (GO:0046185) | 3.94135845 |
| 81 | cellular ketone body metabolic process (GO:0046950) | 3.92610538 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 3.88868359 |
| 83 | regulation of bile acid biosynthetic process (GO:0070857) | 3.88433889 |
| 84 | negative regulation of lipase activity (GO:0060192) | 3.87619625 |
| 85 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.85231501 |
| 86 | ethanol oxidation (GO:0006069) | 3.82748906 |
| 87 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.82467989 |
| 88 | negative regulation of coagulation (GO:0050819) | 3.81173363 |
| 89 | epoxygenase P450 pathway (GO:0019373) | 3.80804839 |
| 90 | glycine metabolic process (GO:0006544) | 3.80256995 |
| 91 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78992894 |
| 92 | negative regulation of wound healing (GO:0061045) | 3.78013762 |
| 93 | positive regulation of blood coagulation (GO:0030194) | 3.77234925 |
| 94 | positive regulation of hemostasis (GO:1900048) | 3.77234925 |
| 95 | protein activation cascade (GO:0072376) | 3.76740883 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.75875537 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.75718513 |
| 98 | serine family amino acid biosynthetic process (GO:0009070) | 3.75357788 |
| 99 | fibrinolysis (GO:0042730) | 3.75165286 |
| 100 | ethanol metabolic process (GO:0006067) | 3.74527872 |
| 101 | plasma lipoprotein particle clearance (GO:0034381) | 3.73897731 |
| 102 | positive regulation of coagulation (GO:0050820) | 3.67532974 |
| 103 | negative regulation of complement activation (GO:0045916) | 3.65967852 |
| 104 | NAD biosynthetic process (GO:0009435) | 3.65955659 |
| 105 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.65274289 |
| 106 | drug transport (GO:0015893) | 3.63339708 |
| 107 | arginine metabolic process (GO:0006525) | 3.63088085 |
| 108 | S-adenosylmethionine metabolic process (GO:0046500) | 3.62027812 |
| 109 | regulation of cholesterol homeostasis (GO:2000188) | 3.61792086 |
| 110 | complement activation, classical pathway (GO:0006958) | 3.60678939 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60505495 |
| 112 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60505495 |
| 113 | drug transmembrane transport (GO:0006855) | 3.60324539 |
| 114 | cholesterol homeostasis (GO:0042632) | 3.59612347 |
| 115 | carboxylic acid catabolic process (GO:0046395) | 3.58315713 |
| 116 | organic acid catabolic process (GO:0016054) | 3.58315713 |
| 117 | intestinal cholesterol absorption (GO:0030299) | 3.56691932 |
| 118 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.56482141 |
| 119 | carnitine metabolic process (GO:0009437) | 3.54633893 |
| 120 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54268733 |
| 121 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.54268733 |
| 122 | sterol homeostasis (GO:0055092) | 3.54086286 |
| 123 | regulation of cholesterol metabolic process (GO:0090181) | 3.53767791 |
| 124 | plasma lipoprotein particle organization (GO:0071827) | 3.51869565 |
| 125 | regulation of humoral immune response (GO:0002920) | 3.48738243 |
| 126 | complement activation (GO:0006956) | 3.38369659 |
| 127 | alkaloid metabolic process (GO:0009820) | 3.35736661 |
| 128 | positive regulation of lipid catabolic process (GO:0050996) | 3.35477813 |
| 129 | daunorubicin metabolic process (GO:0044597) | 3.29399383 |
| 130 | polyketide metabolic process (GO:0030638) | 3.29399383 |
| 131 | doxorubicin metabolic process (GO:0044598) | 3.29399383 |
| 132 | acute-phase response (GO:0006953) | 3.23790535 |
| 133 | protein-lipid complex assembly (GO:0065005) | 3.22758215 |
| 134 | lipoprotein metabolic process (GO:0042157) | 3.15909488 |
| 135 | * xenobiotic metabolic process (GO:0006805) | 3.08112998 |
| 136 | negative regulation of lipid transport (GO:0032369) | 3.01276648 |
| 137 | protein-lipid complex subunit organization (GO:0071825) | 2.99990446 |
| 138 | heme transport (GO:0015886) | 2.99173268 |
| 139 | very long-chain fatty acid metabolic process (GO:0000038) | 2.94544802 |
| 140 | COPII vesicle coating (GO:0048208) | 2.92455196 |
| 141 | regulation of blood coagulation (GO:0030193) | 2.92377455 |
| 142 | regulation of hemostasis (GO:1900046) | 2.92377455 |
| 143 | androgen metabolic process (GO:0008209) | 2.91981110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.63153433 |
| 2 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.69930651 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.53308105 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.10381292 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.81863349 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.58436229 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.92784711 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.75177996 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.67404089 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.32106626 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.12658644 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.41119437 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6711186 |
| 14 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.97427366 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95804388 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.94172722 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.90138868 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88682579 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.80864705 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77769763 |
| 21 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.73516917 |
| 22 | TP53_16413492_ChIP-PET_HCT116_Human | 1.62925729 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57303581 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50285323 |
| 25 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46508308 |
| 26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45212082 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44188466 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43512678 |
| 29 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40312873 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39312757 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36803979 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.34325562 |
| 33 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33559210 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32138648 |
| 35 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.31679653 |
| 36 | CJUN_26792858_Chip-Seq_BT549_Human | 1.31224762 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29920396 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28467979 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26910021 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24988890 |
| 41 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.24513762 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.23304116 |
| 43 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22530359 |
| 44 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22530359 |
| 45 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.22036609 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20870838 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20688826 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14050222 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12858461 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12858461 |
| 51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12693477 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11831739 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10156946 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06330563 |
| 55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04670157 |
| 56 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.04051195 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03331639 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02641959 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01992795 |
| 60 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01390427 |
| 61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00954856 |
| 62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00236911 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.00050156 |
| 64 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99633158 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99231360 |
| 66 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.99165088 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98943952 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98811554 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98248426 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97920965 |
| 71 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.97847787 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97096009 |
| 73 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96366087 |
| 74 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95498270 |
| 75 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95296104 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94048682 |
| 77 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93594695 |
| 78 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93495635 |
| 79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91675752 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91339341 |
| 81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85927578 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85005338 |
| 83 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81208786 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.79758716 |
| 85 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79527244 |
| 86 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79371589 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.79068627 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78983640 |
| 89 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.76517162 |
| 90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76369565 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.75412446 |
| 92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.75138696 |
| 93 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74769451 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.74137135 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69618952 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.69022119 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.68841728 |
| 98 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.67379594 |
| 99 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67236273 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.65717089 |
| 101 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.65540625 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.64908396 |
| 103 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64469600 |
| 104 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.63368044 |
| 105 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.63247825 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63178763 |
| 107 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.62949665 |
| 108 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.62292625 |
| 109 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.61850540 |
| 110 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61843637 |
| 111 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.61839212 |
| 112 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.61794696 |
| 113 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.59399567 |
| 114 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.57595854 |
| 115 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.57158963 |
| 116 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.57083812 |
| 117 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.57050435 |
| 118 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54702993 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54540857 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53653967 |
| 121 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53548343 |
| 122 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.53511002 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.53287457 |
| 124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.52831616 |
| 125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.52691466 |
| 126 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51311893 |
| 127 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.51114598 |
| 128 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.51087610 |
| 129 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.50576146 |
| 130 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49947254 |
| 131 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.49881075 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.48886300 |
| 133 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.48884382 |
| 134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.47762728 |
| 135 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.46638136 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46592130 |
| 137 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.46507508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.82876577 |
| 2 | MP0005360_urolithiasis | 7.32250872 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.28085172 |
| 4 | MP0005365_abnormal_bile_salt | 6.17551614 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.92281541 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.86792365 |
| 7 | MP0003252_abnormal_bile_duct | 3.66347384 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.41868343 |
| 9 | MP0005332_abnormal_amino_acid | 2.75656820 |
| 10 | MP0009840_abnormal_foam_cell | 2.74190479 |
| 11 | MP0005083_abnormal_biliary_tract | 2.72097115 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.61917890 |
| 13 | MP0003195_calcinosis | 2.59740120 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.13430060 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.09460198 |
| 16 | MP0000609_abnormal_liver_physiology | 1.92492039 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 1.91619133 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.90856852 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.84636770 |
| 20 | MP0009697_abnormal_copulation | 1.75686744 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 1.71369229 |
| 22 | MP0002254_reproductive_system_inflammat | 1.69711146 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.69493499 |
| 24 | MP0003868_abnormal_feces_composition | 1.68835373 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.68166007 |
| 26 | MP0001764_abnormal_homeostasis | 1.65732852 |
| 27 | MP0003186_abnormal_redox_activity | 1.65354829 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.47796841 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37432527 |
| 30 | MP0001661_extended_life_span | 1.35635838 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.23185907 |
| 32 | MP0006054_spinal_hemorrhage | 1.22935032 |
| 33 | MP0005451_abnormal_body_composition | 1.20986594 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.20477047 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.20381865 |
| 36 | MP0005647_abnormal_sex_gland | 1.20258309 |
| 37 | MP0003011_delayed_dark_adaptation | 1.16884412 |
| 38 | MP0005023_abnormal_wound_healing | 1.11741000 |
| 39 | MP0002132_abnormal_respiratory_system | 1.05158973 |
| 40 | MP0000598_abnormal_liver_morphology | 1.02415632 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.00354418 |
| 42 | MP0010368_abnormal_lymphatic_system | 0.99068398 |
| 43 | MP0009764_decreased_sensitivity_to | 0.98725598 |
| 44 | MP0009053_abnormal_anal_canal | 0.96887559 |
| 45 | MP0004043_abnormal_pH_regulation | 0.91889877 |
| 46 | MP0009763_increased_sensitivity_to | 0.91870253 |
| 47 | MP0002876_abnormal_thyroid_physiology | 0.88849448 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 0.88523866 |
| 49 | MP0009384_cardiac_valve_regurgitation | 0.88448262 |
| 50 | MP0002166_altered_tumor_susceptibility | 0.87905047 |
| 51 | MP0001915_intracranial_hemorrhage | 0.87253445 |
| 52 | MP0000566_synostosis | 0.84942734 |
| 53 | MP0009765_abnormal_xenobiotic_induced | 0.83039858 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 0.82611398 |
| 55 | MP0005408_hypopigmentation | 0.82525620 |
| 56 | MP0000685_abnormal_immune_system | 0.82309257 |
| 57 | MP0000013_abnormal_adipose_tissue | 0.81966292 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 0.81862324 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 0.81357651 |
| 60 | MP0010678_abnormal_skin_adnexa | 0.78236010 |
| 61 | MP0005499_abnormal_olfactory_system | 0.77867331 |
| 62 | MP0005394_taste/olfaction_phenotype | 0.77867331 |
| 63 | MP0005376_homeostasis/metabolism_phenot | 0.76107568 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 0.75665696 |
| 65 | MP0003690_abnormal_glial_cell | 0.75475986 |
| 66 | MP0003091_abnormal_cell_migration | 0.75312760 |
| 67 | MP0009642_abnormal_blood_homeostasis | 0.74606615 |
| 68 | MP0008469_abnormal_protein_level | 0.73756691 |
| 69 | MP0003763_abnormal_thymus_physiology | 0.73439660 |
| 70 | MP0001873_stomach_inflammation | 0.71589096 |
| 71 | MP0005670_abnormal_white_adipose | 0.70774261 |
| 72 | MP0005409_darkened_coat_color | 0.70529862 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 0.68826898 |
| 74 | MP0004147_increased_porphyrin_level | 0.68235766 |
| 75 | MP0002009_preneoplasia | 0.67176879 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.67020856 |
| 77 | MP0004381_abnormal_hair_follicle | 0.65840944 |
| 78 | MP0002822_catalepsy | 0.65020666 |
| 79 | MP0005266_abnormal_metabolism | 0.64212309 |
| 80 | MP0001756_abnormal_urination | 0.63748315 |
| 81 | MP0002168_other_aberrant_phenotype | 0.63743108 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.63245283 |
| 83 | MP0002896_abnormal_bone_mineralization | 0.62717089 |
| 84 | MP0003866_abnormal_defecation | 0.62549353 |
| 85 | MP0005334_abnormal_fat_pad | 0.61193254 |
| 86 | MP0005220_abnormal_exocrine_pancreas | 0.59944455 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.59595406 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 0.59297618 |
| 89 | MP0002006_tumorigenesis | 0.59000997 |
| 90 | MP0002089_abnormal_postnatal_growth/wei | 0.58942452 |
| 91 | MP0000477_abnormal_intestine_morphology | 0.58478187 |
| 92 | MP0002971_abnormal_brown_adipose | 0.57008054 |
| 93 | MP0001216_abnormal_epidermal_layer | 0.55585660 |
| 94 | MP0000604_amyloidosis | 0.55517435 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.55323109 |
| 96 | MP0002396_abnormal_hematopoietic_system | 0.54424774 |
| 97 | MP0001845_abnormal_inflammatory_respons | 0.53917733 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.53543472 |
| 99 | MP0000003_abnormal_adipose_tissue | 0.53454665 |
| 100 | MP0008872_abnormal_physiological_respon | 0.53339543 |
| 101 | MP0001835_abnormal_antigen_presentation | 0.52952984 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.52644908 |
| 103 | MP0005535_abnormal_body_temperature | 0.51489318 |
| 104 | MP0005166_decreased_susceptibility_to | 0.51474626 |
| 105 | MP0003718_maternal_effect | 0.50905511 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.50623709 |
| 107 | MP0000249_abnormal_blood_vessel | 0.50314511 |
| 108 | MP0002249_abnormal_larynx_morphology | 0.48240640 |
| 109 | MP0004272_abnormal_basement_membrane | 0.48089745 |
| 110 | MP0000467_abnormal_esophagus_morphology | 0.47822040 |
| 111 | MP0005275_abnormal_skin_tensile | 0.47119560 |
| 112 | MP0005187_abnormal_penis_morphology | 0.47007216 |
| 113 | MP0003638_abnormal_response/metabolism_ | 0.46717921 |
| 114 | MP0010030_abnormal_orbit_morphology | 0.46607141 |
| 115 | MP0003724_increased_susceptibility_to | 0.46441681 |
| 116 | MP0001851_eye_inflammation | 0.46368263 |
| 117 | MP0001800_abnormal_humoral_immune | 0.45503501 |
| 118 | MP0005395_other_phenotype | 0.43951532 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.43233363 |
| 120 | MP0003878_abnormal_ear_physiology | 0.43233363 |
| 121 | MP0001790_abnormal_immune_system | 0.43065421 |
| 122 | MP0005387_immune_system_phenotype | 0.43065421 |
| 123 | MP0000538_abnormal_urinary_bladder | 0.42855693 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.41725838 |
| 125 | MP0001984_abnormal_olfaction | 0.41342891 |
| 126 | MP0006036_abnormal_mitochondrial_physio | 0.41096047 |
| 127 | MP0008873_increased_physiological_sensi | 0.40670665 |
| 128 | MP0005164_abnormal_response_to | 0.40061442 |
| 129 | MP0000579_abnormal_nail_morphology | 0.40040360 |
| 130 | MP0002060_abnormal_skin_morphology | 0.39832481 |
| 131 | MP0009115_abnormal_fat_cell | 0.39047483 |
| 132 | MP0000639_abnormal_adrenal_gland | 0.38249153 |
| 133 | MP0001853_heart_inflammation | 0.37252394 |
| 134 | MP0006082_CNS_inflammation | 0.37111695 |
| 135 | MP0004883_abnormal_blood_vessel | 0.36922204 |
| 136 | MP0005448_abnormal_energy_balance | 0.36607722 |
| 137 | MP0001177_atelectasis | 0.35947452 |
| 138 | MP0002796_impaired_skin_barrier | 0.35771612 |
| 139 | MP0005464_abnormal_platelet_physiology | 0.34450656 |
| 140 | MP0002928_abnormal_bile_duct | 0.33179804 |
| 141 | MP0002098_abnormal_vibrissa_morphology | 0.32495298 |
| 142 | MP0003953_abnormal_hormone_level | 0.31816778 |
| 143 | MP0002282_abnormal_trachea_morphology | 0.31601970 |
| 144 | * MP0000163_abnormal_cartilage_morphology | 0.31075829 |
| 145 | MP0003136_yellow_coat_color | 0.30830386 |
| 146 | MP0002233_abnormal_nose_morphology | 0.30341393 |
| 147 | MP0009780_abnormal_chondrocyte_physiolo | 0.30038277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.24033498 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.83855418 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.74548894 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.44384021 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.34088057 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.20698454 |
| 7 | Xanthomatosis (HP:0000991) | 5.99609941 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.09727757 |
| 9 | Complement deficiency (HP:0004431) | 4.84568576 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.80357355 |
| 11 | Joint hemorrhage (HP:0005261) | 4.57163702 |
| 12 | Fat malabsorption (HP:0002630) | 4.43610685 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.41809963 |
| 14 | Abnormality of methionine metabolism (HP:0010901) | 4.37584965 |
| 15 | Epidermoid cyst (HP:0200040) | 4.32688193 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.31588034 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.30408723 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.30167944 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.28108897 |
| 20 | Hyperammonemia (HP:0001987) | 4.24422966 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 4.15345470 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.08480662 |
| 23 | Hyperglycinuria (HP:0003108) | 3.95493352 |
| 24 | Hyperglycinemia (HP:0002154) | 3.95279966 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.78413254 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.78413254 |
| 27 | Ketosis (HP:0001946) | 3.75031248 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.66293489 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.65492505 |
| 30 | Abnormality of complement system (HP:0005339) | 3.63331426 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.50809040 |
| 32 | Steatorrhea (HP:0002570) | 3.47402058 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.32210312 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.25536548 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.22579857 |
| 36 | Myocardial infarction (HP:0001658) | 3.16304092 |
| 37 | Renal cortical cysts (HP:0000803) | 3.05099506 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 2.93500199 |
| 39 | Fair hair (HP:0002286) | 2.93453162 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93156452 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.91883541 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.86947894 |
| 43 | Delayed CNS myelination (HP:0002188) | 2.86807135 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.85450243 |
| 45 | Vascular calcification (HP:0004934) | 2.82648237 |
| 46 | Enlarged kidneys (HP:0000105) | 2.78534904 |
| 47 | Metabolic acidosis (HP:0001942) | 2.65417891 |
| 48 | Spontaneous abortion (HP:0005268) | 2.62996115 |
| 49 | Nephritis (HP:0000123) | 2.61687991 |
| 50 | Hemorrhage of the eye (HP:0011885) | 2.57911976 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.56988426 |
| 52 | Ketoacidosis (HP:0001993) | 2.56478922 |
| 53 | Hypophosphatemic rickets (HP:0004912) | 2.55242832 |
| 54 | Acanthocytosis (HP:0001927) | 2.50088162 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.47047611 |
| 56 | Cardiovascular calcification (HP:0011915) | 2.45401352 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44133196 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.44133196 |
| 59 | Lethargy (HP:0001254) | 2.41281702 |
| 60 | Osteomalacia (HP:0002749) | 2.40425867 |
| 61 | Proximal tubulopathy (HP:0000114) | 2.40386727 |
| 62 | Rickets (HP:0002748) | 2.38251597 |
| 63 | Hydroxyprolinuria (HP:0003080) | 2.35426230 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 2.35426230 |
| 65 | Malnutrition (HP:0004395) | 2.33010481 |
| 66 | Opisthotonus (HP:0002179) | 2.27282354 |
| 67 | Increased mean platelet volume (HP:0011877) | 2.25888404 |
| 68 | Hypoglycemic seizures (HP:0002173) | 2.23256515 |
| 69 | Generalized aminoaciduria (HP:0002909) | 2.22033938 |
| 70 | Hyperactive renin-angiotensin system (HP:0000841) | 2.21516922 |
| 71 | Amyloidosis (HP:0011034) | 2.18724114 |
| 72 | Gout (HP:0001997) | 2.18057241 |
| 73 | Skin nodule (HP:0200036) | 2.17861657 |
| 74 | Periodontitis (HP:0000704) | 2.16374430 |
| 75 | Joint swelling (HP:0001386) | 2.16054950 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.15010297 |
| 77 | Esophageal varix (HP:0002040) | 2.12381579 |
| 78 | Abnormal platelet volume (HP:0011876) | 2.11791138 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.11547302 |
| 80 | Elevated alkaline phosphatase (HP:0003155) | 2.10319779 |
| 81 | Mitral stenosis (HP:0001718) | 2.08571955 |
| 82 | Papillary thyroid carcinoma (HP:0002895) | 2.06519013 |
| 83 | Cerebral edema (HP:0002181) | 2.03559225 |
| 84 | Pancreatitis (HP:0001733) | 2.03515952 |
| 85 | Vitreoretinal degeneration (HP:0000655) | 2.02753680 |
| 86 | Gingival bleeding (HP:0000225) | 2.00953829 |
| 87 | Abnormal cartilage morphology (HP:0002763) | 2.00674077 |
| 88 | Generalized hypopigmentation of hair (HP:0011358) | 1.99816854 |
| 89 | Cholelithiasis (HP:0001081) | 1.96803557 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95570936 |
| 91 | Menorrhagia (HP:0000132) | 1.92768150 |
| 92 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91383830 |
| 93 | Vomiting (HP:0002013) | 1.90866450 |
| 94 | Irritability (HP:0000737) | 1.90467084 |
| 95 | Abnormality of urine glucose concentration (HP:0011016) | 1.89255359 |
| 96 | Glycosuria (HP:0003076) | 1.89255359 |
| 97 | Spastic diplegia (HP:0001264) | 1.88835059 |
| 98 | Poikilocytosis (HP:0004447) | 1.88590187 |
| 99 | Cholecystitis (HP:0001082) | 1.87620592 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 1.87620592 |
| 101 | Chronic diarrhea (HP:0002028) | 1.86730153 |
| 102 | * Flat acetabular roof (HP:0003180) | 1.86304664 |
| 103 | Thrombophlebitis (HP:0004418) | 1.86113958 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.86043323 |
| 105 | Abdominal distention (HP:0003270) | 1.85779868 |
| 106 | * Abnormal tarsal ossification (HP:0008369) | 1.84678537 |
| 107 | Glomerulonephritis (HP:0000099) | 1.84663157 |
| 108 | Abnormality of vitamin metabolism (HP:0100508) | 1.83916956 |
| 109 | Confusion (HP:0001289) | 1.83246411 |
| 110 | Decreased circulating renin level (HP:0003351) | 1.82970658 |
| 111 | Alkalosis (HP:0001948) | 1.82741320 |
| 112 | Neonatal onset (HP:0003623) | 1.82369467 |
| 113 | Abnormality of the gallbladder (HP:0005264) | 1.82250190 |
| 114 | Brushfield spots (HP:0001088) | 1.81214787 |
| 115 | Conjunctival telangiectasia (HP:0000524) | 1.79056050 |
| 116 | Elevated hepatic transaminases (HP:0002910) | 1.78238705 |
| 117 | Arthropathy (HP:0003040) | 1.76841471 |
| 118 | Alveolar cell carcinoma (HP:0006519) | 1.73911944 |
| 119 | Abnormal delivery (HP:0001787) | 1.73004960 |
| 120 | Thickened calvaria (HP:0002684) | 1.72599452 |
| 121 | Epistaxis (HP:0000421) | 1.68852858 |
| 122 | Pulmonary embolism (HP:0002204) | 1.68548362 |
| 123 | Lower limb hyperreflexia (HP:0002395) | 1.64501548 |
| 124 | Large earlobe (HP:0009748) | 1.62283810 |
| 125 | Neonatal short-limb short stature (HP:0008921) | 1.61579364 |
| 126 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.60737729 |
| 127 | * Abnormality of carpal bone ossification (HP:0006257) | 1.58610375 |
| 128 | Protuberant abdomen (HP:0001538) | 1.58081967 |
| 129 | Right ventricular cardiomyopathy (HP:0011663) | 1.56288984 |
| 130 | Osteolytic defects of the hand bones (HP:0009699) | 1.56272080 |
| 131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.56272080 |
| 132 | Mucopolysacchariduria (HP:0008155) | 1.55371907 |
| 133 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.55371907 |
| 134 | Coarse hair (HP:0002208) | 1.53960785 |
| 135 | Abnormality of the gastric mucosa (HP:0004295) | 1.52016398 |
| 136 | Purpura (HP:0000979) | 1.51064176 |
| 137 | Submucous cleft hard palate (HP:0000176) | 1.50455349 |
| 138 | Ileus (HP:0002595) | 1.47904868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.58769172 |
| 2 | SIK1 | 3.48095531 |
| 3 | FRK | 3.38676382 |
| 4 | FGFR4 | 3.31232349 |
| 5 | INSRR | 3.02758437 |
| 6 | ACVR1B | 2.88759503 |
| 7 | CDK12 | 2.78150058 |
| 8 | ERBB4 | 2.71754442 |
| 9 | MAP3K3 | 2.70231120 |
| 10 | ERN1 | 2.58899216 |
| 11 | MAP2K3 | 2.36861846 |
| 12 | MST1R | 2.32202905 |
| 13 | PRPF4B | 2.14055400 |
| 14 | LATS1 | 2.13607495 |
| 15 | NUAK1 | 2.09300223 |
| 16 | MAP2K4 | 1.96850795 |
| 17 | PBK | 1.90286205 |
| 18 | PIK3CA | 1.89384371 |
| 19 | MAP3K2 | 1.83430612 |
| 20 | TAOK3 | 1.83032599 |
| 21 | STK24 | 1.79607581 |
| 22 | MAP3K14 | 1.74732881 |
| 23 | CDK9 | 1.72724443 |
| 24 | EIF2AK3 | 1.69608024 |
| 25 | STK38L | 1.65259616 |
| 26 | NEK9 | 1.62786127 |
| 27 | MAPK15 | 1.62612292 |
| 28 | RIPK1 | 1.53620888 |
| 29 | TRPM7 | 1.53096477 |
| 30 | STK39 | 1.49272100 |
| 31 | MAPK11 | 1.46981293 |
| 32 | MAP3K13 | 1.45825794 |
| 33 | ZAK | 1.40097427 |
| 34 | AKT3 | 1.34972731 |
| 35 | MAPK7 | 1.34910848 |
| 36 | TAOK2 | 1.34151068 |
| 37 | KSR2 | 1.34095178 |
| 38 | SGK2 | 1.33030742 |
| 39 | IRAK3 | 1.24307989 |
| 40 | MAP2K6 | 1.23578757 |
| 41 | BRSK2 | 1.23079607 |
| 42 | BRD4 | 1.21730044 |
| 43 | EPHB2 | 1.21471686 |
| 44 | ERBB2 | 1.19758329 |
| 45 | SGK3 | 1.19128726 |
| 46 | JAK3 | 1.18611060 |
| 47 | PIK3CG | 1.18251777 |
| 48 | PINK1 | 1.16372478 |
| 49 | MAP3K10 | 1.14152145 |
| 50 | PDGFRA | 1.13942783 |
| 51 | CDK6 | 1.13118215 |
| 52 | ABL2 | 1.12859081 |
| 53 | MAP3K6 | 1.04896177 |
| 54 | TYK2 | 1.02856231 |
| 55 | PKN2 | 0.98296439 |
| 56 | CSF1R | 0.97879309 |
| 57 | MAPK12 | 0.97124393 |
| 58 | MAPK4 | 0.96906191 |
| 59 | PRKAA2 | 0.95275352 |
| 60 | MAP3K12 | 0.93610332 |
| 61 | MELK | 0.93244658 |
| 62 | RAF1 | 0.92584058 |
| 63 | NEK6 | 0.88195974 |
| 64 | EPHB1 | 0.85610698 |
| 65 | FGFR2 | 0.84777775 |
| 66 | GRK6 | 0.83935676 |
| 67 | SGK223 | 0.82882889 |
| 68 | SGK494 | 0.82882889 |
| 69 | MET | 0.80564219 |
| 70 | WNK4 | 0.79135118 |
| 71 | STK38 | 0.78460057 |
| 72 | PTK6 | 0.78201457 |
| 73 | EPHA3 | 0.77896309 |
| 74 | PDK1 | 0.76765156 |
| 75 | JAK2 | 0.76642033 |
| 76 | NLK | 0.75878474 |
| 77 | GRK1 | 0.74984600 |
| 78 | GSK3A | 0.74390225 |
| 79 | MAP2K2 | 0.73524707 |
| 80 | JAK1 | 0.72908593 |
| 81 | FLT3 | 0.71076041 |
| 82 | MAP3K5 | 0.70666393 |
| 83 | PRKG2 | 0.69490833 |
| 84 | WNK1 | 0.68678556 |
| 85 | TIE1 | 0.68340141 |
| 86 | PDPK1 | 0.67938428 |
| 87 | PDK2 | 0.66373753 |
| 88 | KSR1 | 0.64920373 |
| 89 | MAP3K7 | 0.64588637 |
| 90 | LMTK2 | 0.64454183 |
| 91 | RET | 0.64428463 |
| 92 | IKBKE | 0.63242641 |
| 93 | TXK | 0.63032517 |
| 94 | MST4 | 0.62480305 |
| 95 | ZAP70 | 0.61954161 |
| 96 | CSNK1G1 | 0.60761480 |
| 97 | SIK3 | 0.60316043 |
| 98 | FER | 0.59799752 |
| 99 | IGF1R | 0.59749162 |
| 100 | CSNK1A1L | 0.58951828 |
| 101 | PRKCQ | 0.58312578 |
| 102 | STK3 | 0.57876996 |
| 103 | MAP3K1 | 0.56995484 |
| 104 | CDK8 | 0.56462851 |
| 105 | MAP3K11 | 0.56018460 |
| 106 | PDGFRB | 0.55419748 |
| 107 | FGFR3 | 0.55118921 |
| 108 | DAPK2 | 0.53135751 |
| 109 | KDR | 0.52267325 |
| 110 | ERBB3 | 0.51912370 |
| 111 | CSK | 0.51728565 |
| 112 | MAP4K1 | 0.51348925 |
| 113 | ICK | 0.51136301 |
| 114 | TRIB3 | 0.50398595 |
| 115 | BCR | 0.50031964 |
| 116 | EPHA2 | 0.49244577 |
| 117 | CAMK2G | 0.49119345 |
| 118 | TBK1 | 0.48999227 |
| 119 | PRKACG | 0.47768319 |
| 120 | ADRBK2 | 0.47243171 |
| 121 | MAPK3 | 0.45507985 |
| 122 | CASK | 0.45413924 |
| 123 | TNK2 | 0.44977328 |
| 124 | PTK2 | 0.44609440 |
| 125 | PRKAA1 | 0.44421847 |
| 126 | MYLK | 0.42328170 |
| 127 | PRKCZ | 0.41872507 |
| 128 | PIM1 | 0.41450158 |
| 129 | MTOR | 0.41354366 |
| 130 | CDC42BPA | 0.41010618 |
| 131 | DDR2 | 0.40384857 |
| 132 | IKBKB | 0.39685348 |
| 133 | MATK | 0.39485329 |
| 134 | BTK | 0.38724936 |
| 135 | CAMKK2 | 0.35988871 |
| 136 | KIT | 0.35936543 |
| 137 | MAP2K1 | 0.35753478 |
| 138 | RPS6KB1 | 0.35590329 |
| 139 | TGFBR2 | 0.35341052 |
| 140 | CHUK | 0.34276071 |
| 141 | IRAK1 | 0.33932141 |
| 142 | PRKCA | 0.33797478 |
| 143 | BLK | 0.33549609 |
| 144 | ABL1 | 0.32899465 |
| 145 | CDK4 | 0.30719777 |
| 146 | ITK | 0.30161142 |
| 147 | BMPR2 | 0.29538433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.20750103 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.85810631 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.02408245 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.00691215 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.67366978 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.66674252 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66418941 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57168687 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53475368 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.47171058 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.43998057 |
| 12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.40752090 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36501200 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.36279335 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.27875084 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.21015444 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19867901 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18912810 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.05502626 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.04817059 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02724961 |
| 22 | Retinol metabolism_Homo sapiens_hsa00830 | 1.97350802 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96277907 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.89711143 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78146650 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76606381 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74945014 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73760707 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.64054603 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59839249 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55895826 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.51571488 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50868963 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49295753 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48710206 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46742704 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44541767 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.41081637 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.35738258 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32678571 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.26624241 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24884448 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19511129 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18305880 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17236256 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15571005 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11785661 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10270017 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07535656 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.06260909 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05276808 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01103334 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98665754 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95744474 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95240117 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86295739 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83946353 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81793346 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80215670 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78784697 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76761398 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73723653 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61854432 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61718959 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53844747 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51296743 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48652917 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48167176 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43451618 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37603454 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.28277686 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26495392 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23636714 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21989521 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.20363975 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20236488 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.17309933 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16617048 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15763924 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.15536937 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12032028 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10097691 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.09846231 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.09773463 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09559971 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.09309075 |
| 87 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.09215861 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.08482344 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07714970 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.07714063 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.07691631 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.07612466 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07537029 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07341242 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06930931 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05839515 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.04862896 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.02982458 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02783836 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01323418 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.2182785 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.2142230 |
| 103 | Pertussis_Homo sapiens_hsa05133 | -0.2104087 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | -0.2000357 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1979719 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1893451 |
| 107 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1734839 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1544658 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1323431 |
| 110 | Malaria_Homo sapiens_hsa05144 | -0.1202668 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1124979 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | -0.0840610 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0739216 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0636854 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0589271 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0428290 |
| 117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0163433 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0047434 |

